The $19 valuation does not seem far off to me. At a simplistic level:
QBE has forecast NEP at $US15.5B - $US16B, and an insurance profit margin of 11%.
So insurance profit is forecast at $US1.71B - $1.76B.
Add earnings on shareholder funds of ±$US0.2B and subtract interest costs of $±$US0.3B, and you get profit before tax of $US1.61B - $1.66B (assuming no further writedowns of intangibles this year).
Historical tax rates have been around 20%, so profit after tax of $US1.29B - $1.33B. This equates to earnings per share of $US1.06 - $US1.09 per share. At current exchange rates that is $AUD1.17 to $AUD1.21 per share. Current market (and industry average) p/e is around 14.6, which would give a valuation of $17.08 to $17.66.
But this does not account for:
- the increase in discount rates which is massively to QBE's benefit;
- the increase in investment income that will result from higher interest rates in the US;
- the (to date) benign catastrophe environment;
- the cost reduction measures;
- ongoing above inflation increases in premium rates;
- any upside in the US business (such as is happening in crop right now).
Net result is that I am very comfortable holding at these levels, at least to see what comes out of the half year results.
- Forums
- ASX - By Stock
- transformational update expectations....
The $19 valuation does not seem far off to me. At a simplistic...
Featured News
Add QBE (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.31 |
Change
0.320(1.69%) |
Mkt cap ! $29.06B |
Open | High | Low | Value | Volume |
$18.99 | $19.33 | $18.92 | $82.26M | 4.271M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 129 | $19.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.32 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 19.260 |
2 | 3935 | 19.230 |
1 | 8400 | 19.210 |
1 | 45301 | 19.200 |
2 | 15505 | 19.190 |
Price($) | Vol. | No. |
---|---|---|
19.320 | 500 | 1 |
19.330 | 1126 | 1 |
19.340 | 1275 | 1 |
19.350 | 10879 | 5 |
19.360 | 10 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
QBE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online